Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Angiotensin 1/2 (1-6): Benchmark Hexapeptide for Renin-An...

    2026-03-20

    Angiotensin 1/2 (1-6): Benchmark Hexapeptide for Renin-Angiotensin System Research

    Executive Summary: Angiotensin 1/2 (1-6) (Asp-Arg-Val-Tyr-Ile-His) is a hexapeptide fragment derived from the N-terminus of angiotensin I and II, central to renin-angiotensin system (RAS) investigations [APExBIO product page]. It acts as a potent vasoconstrictor, modulating vascular tone and stimulating aldosterone release in vitro and in vivo [Oliveira et al., 2025]. This peptide exhibits enhanced activity in viral pathogenesis models, notably promoting SARS-CoV-2 spike–AXL binding [DOI]. Angiotensin 1/2 (1-6) demonstrates robust solubility in water (≥62.4 mg/mL) and DMSO (≥80.2 mg/mL), but is insoluble in ethanol and stable at -20°C [product info]. It is not intended for diagnostic or therapeutic use but is validated for cardiovascular and renal physiology research.

    Biological Rationale

    Angiotensin 1/2 (1-6) is a hexapeptide fragment (Asp-Arg-Val-Tyr-Ile-His) produced by sequential proteolytic cleavage of angiotensinogen, a liver-synthesized glycoprotein. The classical renin-angiotensin system (RAS) pathway involves conversion of angiotensinogen to angiotensin I (1-10) by renin, followed by further cleavage via angiotensin-converting enzyme (ACE) to angiotensin II (1-8) [Oliveira et al., 2025]. Angiotensin 1/2 (1-6) arises from C-terminal truncation of angiotensin II, retaining the N-terminal sequence that interacts with specific vascular and renal receptors. This peptide regulates blood pressure, vascular tone, and renal sodium handling—key endpoints in cardiovascular and renal disease research [Related article]. While previous reviews focus on whole-molecule angiotensin II, this article extends mechanistic insight to the 1-6 fragment, emphasizing its unique experimental utility.

    Mechanism of Action of Angiotensin 1/2 (1-6)

    Angiotensin 1/2 (1-6) acts as a vasoconstrictor peptide by directly influencing vascular smooth muscle cell contraction. The hexapeptide binds to the type 1 angiotensin II receptor (AT1R), a G protein-coupled receptor (GPCR), initiating intracellular signaling cascades that elevate cytosolic calcium and promote constriction [Oliveira et al., 2025]. This triggers aldosterone release from the adrenal cortex, increasing sodium retention and blood pressure. The presence of the tyrosine residue at position 4 is critical for activity, as shown by mutational studies; substitution or phosphorylation at this site modulates receptor interaction and downstream effects [DOI]. Unlike the full-length angiotensin II, the 1-6 fragment shows selectivity for certain RAS receptors and may have differential potency in modulating AXL-mediated viral entry pathways. This mechanistic precision enables targeted studies in hypertension, renal function, and viral pathogenesis [Contrasts by focusing on viral mechanisms].

    Evidence & Benchmarks

    • Angiotensin 1/2 (1-6) increases vascular tone by direct AT1R activation in vitro, as assessed by smooth muscle contraction assays (Oliveira et al., 2025, DOI).
    • This peptide fragment stimulates aldosterone secretion in adrenal cell cultures at concentrations ≥100 nM, under physiological pH 7.4 and 37°C (Oliveira et al., 2025, DOI).
    • In antibody-based binding assays, angiotensin 1/2 (1-6) enhances SARS-CoV-2 spike–AXL binding with similar efficacy to angiotensin II at 100 nM (Oliveira et al., 2025, DOI).
    • The Asp-Arg-Val-Tyr-Ile-His hexapeptide is water-soluble (≥62.4 mg/mL) and DMSO-soluble (≥80.2 mg/mL) at ambient temperature, but insoluble in ethanol (APExBIO).
    • Storage at -20°C preserves >98% peptide integrity for ≥12 months, as confirmed by HPLC (APExBIO, product page).

    This article updates prior reviews by integrating recent evidence on viral entry mechanisms and benchmarking physicochemical standards. For a broader discussion on mechanistic precision, see this strategic insights article, which our review expands by detailing solubility and receptor specificity.

    Applications, Limits & Misconceptions

    Angiotensin 1/2 (1-6) is widely used in cardiovascular physiology, renal function research, and viral pathogenesis models. It serves as a reference compound for dissecting vasoconstriction mechanisms, aldosterone signaling, and blood pressure regulation [Previously focused on hypertension; this article adds viral dimension]. The peptide’s stability, solubility, and sequence fidelity make it a reliable tool for quantitative and mechanistic assays.

    Common Pitfalls or Misconceptions

    • Angiotensin 1/2 (1-6) is not suitable as a therapeutic agent; it is for research use only (APExBIO).
    • The peptide does not replicate all effects of full-length angiotensin II, especially regarding AT2R-mediated vasodilation (DOI).
    • It is not a diagnostic reagent and should not be used in clinical assays.
    • Solubility is compromised in ethanol; use water or DMSO for experimental formulations (product info).
    • Misinterpretation may occur if used outside validated concentrations (typically 10–1000 nM in vitro).

    Workflow Integration & Parameters

    Researchers can incorporate Angiotensin 1/2 (1-6) (A1048) directly into in vitro, ex vivo, or in vivo protocols. Stock solutions should be prepared in sterile water (≥62.4 mg/mL) or DMSO (≥80.2 mg/mL), with aliquots stored at -20°C to prevent degradation. Recommended working concentrations range from 10 nM to 1 μM for cell-based assays. The peptide’s high purity and sequence specificity facilitate reproducible results in vascular reactivity, aldosterone release, and receptor binding studies [Compared to broader overviews, this section details preparation and storage]. For comprehensive product data, see the Angiotensin 1/2 (1-6) A1048 kit from APExBIO.

    Conclusion & Outlook

    Angiotensin 1/2 (1-6) is an essential tool for dissecting renin-angiotensin system signaling, vascular tone modulation, and aldosterone-mediated pathways. Recent studies underscore its role in viral pathogenesis, notably in SARS-CoV-2 spike–AXL interactions. With robust physicochemical properties and validated workflow performance, this hexapeptide fragment is set to remain a benchmark reagent for cardiovascular, renal, and infectious disease research. APExBIO provides high-purity Angiotensin 1/2 (1-6) for advanced mechanistic studies.